Surgery for stomach cancer that spread to the liver
Part of Cancer, Digestive system clinical trials.
This trial tests if removing the stomach tumor and liver spots together can help people with stomach cancer that has spread only to the liver. It is for those who are healthy enough for surgery and chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stomach or GEJ cancer that has spread to the liver, but less than 30% of your liver is involved.
- Your main tumor can be removed with surgery, based on scans.
- You are healthy enough for surgery (ASA score 3 or lower) and can care for yourself (WHO score 0 or 1).
- You are able to receive a specific chemotherapy regimen called FLOT.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with stomach cancer that has spread to the liver to learn more about their health over time. It may help doctors understand how to better care for people with this condition.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
This trial tests a combination of treatments for stomach cancer that has spread to the liver. It combines a procedure that blocks blood flow to the liver tumor (TACE), heat/cold ablation to destroy it, and medications (chemotherapy, an antibody-drug conjugate, and an immunotherapy) to fight the cancer throughout the body.
This trial studies whether a specific surgery that removes the colon’s associated tissue (and part of the nearby stomach-area tissue) improves outcomes for certain colon cancer cases that are at risk of spreading there. If you qualify, your doctors will compare your treatment approach as part of the study to see if it helps.
This trial tests a combination of three drugs — an immunotherapy (sintilimab), a targeted therapy (bevacizumab), and chemotherapy — for a specific type of stomach cancer that produces high AFP and has spread to the liver. The goal is to see if this treatment can shrink tumors enough to make them removable by surgery.
This trial tests a combination of chemotherapy (conversion therapy), surgery, and radiation for people with stomach cancer that has spread only to lymph nodes behind the stomach. The goal is to see if this approach can help shrink the cancer and improve outcomes.
Hear when a new Survival trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.